B
Barbara A. Booth
Researcher at United States Department of Veterans Affairs
Publications - 6
Citations - 446
Barbara A. Booth is an academic researcher from United States Department of Veterans Affairs. The author has contributed to research in topics: Endothelial stem cell & Growth factor. The author has an hindex of 6, co-authored 6 publications receiving 436 citations.
Papers
More filters
Journal ArticleDOI
The Effects of Platelet-Derived Growth Factor in Cultured Microvessel Endothelial Cells*
TL;DR: It is concluded that these two cultured microvessel endothelial cells not only produce PDGF-like material, but are capable of binding and responding to PDGF.
Journal Article
IGFBP-3 and IGFBP-5 association with endothelial cells: role of C-terminal heparin binding domain.
Barbara A. Booth,Boes M,Andress Dl,Dake Bl,Kiefer Mc,Maack C,Robert J. Linhardt,Bar K,Elizabeth E.O. Caldwell,John M. Weiler +9 more
TL;DR: It is suggested that the C-terminal basic segment of IGFBP-3/-5 is important for the association of the binding protein with the EC monolayer.
Journal ArticleDOI
IGFBP-3 proteolysis by plasmin, thrombin, serum: heparin binding, IGF binding, and structure of fragments
TL;DR: It is suggested that proteolytic fragments exposed to plasmin, thrombin, and pregnancy serum have the potential to alter regional vascular concentrations of IGF and thus influence both IGF and endothelial function.
Journal ArticleDOI
Insulin-like growth factor binding protein (IGFBP)4 accounts for the connective tissue distribution of endothelial cell IGFBPs perfused through the isolated heart.
TL;DR: It is concluded that the connective tissue distribution previously reported for IGFBPs in conditioned media of pulmonary artery endothelial cells is due to IGFBP4.
Journal ArticleDOI
Intrinsic Bioactivity of Insulin-Like Growth Factor-Binding Proteins from Vascular Endothelial Cells*
TL;DR: This paper showed that the bioactivity of the conditioned medium is not caused by the copurification of known growth factors produced by the cells, in particular platelet-derived growth factor, basic fibroblast growth factor or insulin-like growth factor (IGF)-I/II.